StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3
Publishing Date
2021 - 06 - 04
3
Sector
Health technology
3
Tags
Car-t
1
Clinical-trials-phase-ii
1
Designation
1
Iot
1
Leukemia
1
N/a
2
Phase 1
1
Phase 2
1
Phase 3
1
Positive
1
T-cell
3
Therapy
1
Entities
Anixa biosciences, inc.
1
Bellicum pharmaceuticals, inc.
1
Bristol-myers squibb company
1
Fate therapeutics, inc.
2
Gilead sciences, inc.
2
Mustang bio, inc.
1
Poseida therapeutics, inc.
1
Precigen, inc.
1
Sorrento therapeutics, inc.
1
Symbols
ANIX
1
BLCM
1
BMY
1
FATE
2
GILD
2
MBIO
1
PGEN
1
PSTX
1
SRNE
1
Exchanges
Nasdaq
3
Nyse
1
Crawled Date
2024 - 03 - 18
3
2024 - 02 - 08
3
2023 - 11 - 06
5
2023 - 09 - 27
3
2023 - 07 - 06
4
2023 - 06 - 05
4
2023 - 04 - 18
3
2023 - 04 - 17
5
2023 - 02 - 09
3
2023 - 01 - 26
3
2022 - 12 - 11
3
2022 - 11 - 10
6
2022 - 11 - 09
4
2022 - 11 - 07
3
2022 - 10 - 05
6
2022 - 06 - 07
3
2022 - 04 - 25
3
2022 - 04 - 14
3
2022 - 04 - 13
3
2022 - 04 - 08
4
2022 - 03 - 08
3
2022 - 02 - 17
3
2021 - 12 - 13
10
2021 - 12 - 09
6
2021 - 12 - 06
3
2021 - 12 - 02
5
2021 - 11 - 29
3
2021 - 11 - 12
4
2021 - 11 - 09
3
2021 - 11 - 04
3
2021 - 10 - 04
4
2021 - 09 - 02
2
2021 - 09 - 01
2
2021 - 08 - 24
2
2021 - 08 - 19
2
2021 - 08 - 11
2
2021 - 08 - 02
2
2021 - 07 - 21
2
2021 - 06 - 25
3
2021 - 06 - 22
2
2021 - 06 - 11
3
2021 - 06 - 07
2
2021 - 06 - 04
3
2021 - 05 - 25
2
2021 - 05 - 20
2
2021 - 05 - 11
4
2021 - 05 - 10
2
2021 - 04 - 28
2
2021 - 04 - 23
3
2021 - 02 - 23
2
2021 - 02 - 03
2
2021 - 01 - 19
3
2021 - 01 - 14
2
2021 - 01 - 07
2
2021 - 01 - 04
2
2020 - 12 - 24
2
2020 - 12 - 15
2
2020 - 12 - 07
4
2020 - 12 - 05
2
2020 - 12 - 04
2
Crawled Time
12:00
1
16:00
1
20:00
1
Source
www.biospace.com
1
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
t-cell
crawled date :
2021 - 06 - 04
save search
Kite's Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Earning Priority Review Designation
Published:
2021-06-04
(Crawled : 20:00)
- biospace.com/
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.9%
|
O:
0.47%
H:
1.17%
C:
0.96%
leukemia
t-cell
designation
Worldwide CAR-T Cell Therapy Industry - Featuring Aleta BioTherapeutics, Atara Biotherapeutics and BioNTech Among Others
Published:
2021-06-04
(Crawled : 16:00)
- prnewswire.com
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.6%
|
O:
0.28%
H:
0.38%
C:
-0.06%
SRNE
|
$0.015
-8.85%
56K
|
Health Technology
|
-99.88%
|
O:
1.73%
H:
2.43%
C:
-1.58%
PGEN
|
$1.42
1.43%
1.41%
560K
|
Health Technology
|
-78.39%
|
O:
1.07%
H:
3.01%
C:
0.45%
PSTX
|
$2.065
-4.4%
-4.6%
350K
|
Health Technology
|
-75.36%
|
O:
-1.07%
H:
2.53%
C:
0.84%
MBIO
|
$0.35
-2.7%
-2.77%
120K
|
Health Technology
|
-89.23%
|
O:
2.46%
H:
8.41%
C:
6.91%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.9%
|
O:
0.47%
H:
1.17%
C:
0.96%
FATE
|
News
|
$4.3
-5.29%
-5.58%
2M
|
Health Technology
|
-93.61%
|
O:
1.53%
H:
9.81%
C:
6.61%
BLCM
|
$0.0748
381.28%
6.1K
|
Health Technology
|
-97.44%
|
O:
0.0%
H:
2.74%
C:
0.68%
ANIX
|
$3.1
0.98%
0.97%
360K
|
Health Technology
|
-19.08%
|
O:
1.78%
H:
6.25%
C:
3.0%
therapy
car-t
iot
t-cell
Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting
Published:
2021-06-04
(Crawled : 12:00)
- globenewswire.com
FATE
|
News
|
$4.3
-5.29%
-5.58%
2M
|
Health Technology
|
-93.61%
|
O:
1.53%
H:
9.81%
C:
6.61%
phase 1
positive
phase 3
phase 2
t-cell
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.